Global Ophthalmology Therapeutics Market 2019-2023 – Key Players are Allergan, F. Hoffmann-La Roche, Novartis, Regeneron Pharmaceuticals, and Santen Pharmaceutical

DUBLIN–(BUSINESS WIRE)–The “Global
Ophthalmology Therapeutics Market 2019-2023” report has been
added to ResearchAndMarkets.com’s offering.

The ophthalmology therapeutics market will register a CAGR of nearly 6%
by 2023.

The new drug approvals and strong drug pipeline will trigger the
ophthalmology therapeutics market growth in the forthcoming years.

Top players in the market are focusing on the development of
disease-modifying drugs for treating the rising incidences of eye
diseases. Furthermore, several market players are focusing on achieving
new drug approvals and gene therapy approvals for treating the eye
diseases, thus, contributing significantly to the market growth.

New drug approvals and strong drug pipeline

One of the growth drivers of the global ophthalmology therapeutics
market is new drug approvals and strong drug pipeline. The increasing
incidence of eye disease is encouraging the top players to focus on the
development of disease-modifying drugs to treat these diseases, which
will drive the growth of the market during the forecast period.

High cost of treatment

One of the challenges in the growth of the global ophthalmology
therapeutics market is the high cost of treatment. The high cost
involved in treating various eye diseases can hamper the growth of the
market.

Competitive Landscape

The market appears to be fragmented and with the presence of several
market players. Companies are focusing on developing innovative
treatments for glaucoma and other eye conditions.

This market research report will help clients identify new growth
opportunities and design unique growth strategies by providing a
comprehensive analysis of the market’s competitive landscape and
offering information on the products offered by companies.

Key Players

• Allergan
• F. Hoffmann-La Roche
• Novartis
• Regeneron Pharmaceuticals
• Santen Pharmaceutical

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

• Comparison by product
• Retinal disorder therapeutics – Market size and forecast 2018-2023
• Glaucoma therapeutics – Market size and forecast 2018-2023
• Dry eye syndrome therapeutics – Market size and forecast 2018-2023
• Eye infections and inflammation therapeutics – Market size and
  forecast 2018-2023
• Other therapeutics – Market size and forecast 2018-2023
• Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• RoW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

• Overview
• Landscape disruption

PART 13: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Allergan
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Regeneron Pharmaceuticals Inc.
• Santen Pharmaceutical Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/k574gj

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Optical